Generic Vytorin is used for treating high cholesterol along with a cholesterol-lowering diet. It works by reducing the amount of cholesterol that your body absorbs from your meals. Lowering cholesterol levels in the blood reduces the chance of heart disease, heart attacks and strokes. More info »
Generic Zetia is used for treating high blood cholesterol along with a low-fat, low-cholesterol diet. It may be used alone or with other medicines. It is also used to treat high blood sitosterol and campesterol along with diet therapy. More info »
Your email was addressed as a survey and the only link was the one I am responding to now.
To question #1; Did I receive the medication shipment as ordered?
The answer is yes, and I was impressed with the time in which it was delivered to my home; only 10 days!
To question #2; did the medication meet my expectations?
Again the answer is yes! I was also impressed with your website which explains everything about ordering outside the U.S., quality of the medication made at the India labs, number(s) to call if the shipment is held up in Customs, and the ease in placing the order.
- Dave
Merck wins patent fight on Zetia, Vytorin; Fitch warns of 'pure pharma' risks; - FiercePharma
Merck wins patent fight on Zetia, Vytorin; Fitch warns of 'pure pharma' risks;FiercePharmaArticle | Follow @FiercePharma > A US court upheld Merck's ($MRK) patent on the active ingredient ezetimibe, marketed as the cholesterol-lowering Zetia and in the combo cholesterol pill Vytorin.
Investor Medical Waves - (VVUS, MRK, MYL, AMPE)Galaxy StocksInc.
Advanced Atherosclerosis: The Heart and Beyond - Medscape
Advanced Atherosclerosis: The Heart and BeyondMedscapeThe premise of AIM-HIGH was to see if adding extended-release niacin to raise HDL cholesterol in patients who had already achieved a very low LDL cholesterol level (40 to 80 mg/dL) with simvastatin (and ezetimibe if needed) would lead to further risk .
Toward Regenerative Medicine Against Atherosclerosis cardiovascular disease - Next Big Future
Toward Regenerative Medicine Against Atherosclerosis cardiovascular diseaseNext Big FutureOnce-promizing agents such as ezetimibe, niacin, ApoA-1 Milano, and torcetrapib have either been found to provide no benefit, or evento increase mortality rates.